Caas Capital Management LP bought a new position in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 59,000 shares of the company's stock, valued at approximately $1,470,000. Caas Capital Management LP owned approximately 0.11% of Kestra Medical Technologies as of its most recent filing with the Securities and Exchange Commission (SEC).
Separately, Brown Advisory Inc. acquired a new position in Kestra Medical Technologies in the 1st quarter worth approximately $13,716,000.
Analysts Set New Price Targets
Several equities analysts recently weighed in on the stock. Wolfe Research initiated coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an "outperform" rating and a $29.00 price target on the stock. Stifel Nicolaus started coverage on Kestra Medical Technologies in a report on Monday, March 31st. They issued a "buy" rating and a $28.00 price objective on the stock. Bank of America started coverage on Kestra Medical Technologies in a report on Monday, March 31st. They set a "buy" rating and a $30.00 price target on the stock. Wells Fargo & Company began coverage on Kestra Medical Technologies in a report on Monday, March 31st. They set an "overweight" rating and a $28.00 price target on the stock. Finally, Piper Sandler assumed coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an "overweight" rating and a $27.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $27.50.
Check Out Our Latest Stock Report on Kestra Medical Technologies
Kestra Medical Technologies Price Performance
NASDAQ KMTS traded down $0.28 during trading on Friday, hitting $14.91. The stock had a trading volume of 310,381 shares, compared to its average volume of 458,089. Kestra Medical Technologies, Ltd. has a twelve month low of $14.02 and a twelve month high of $26.15. The business's 50 day moving average is $19.53.
Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last announced its quarterly earnings data on Monday, April 14th. The company reported ($1.25) EPS for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.61). During the same period last year, the business earned ($1.18) earnings per share.
Kestra Medical Technologies Profile
(
Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Featured Stories
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
